摘要
目的观察经导管肝动脉化疗栓塞术(TACE)治疗中晚期原发性肝癌的疗效、毒副反应。方法采用Seldinger技术,经股动脉穿剌,选择性肝动脉插管灌注化疗药物联合碘油栓塞或加用明胶海绵治疗中晚期原发性肝癌患者120例,共行280次介入治疗。结果全组120例患者中,完全缓解60.0%(72/120),部分缓解31.7%(38/120),稳定8.3%(10/120),12个月以上生存率达63.3%(76/120)。结论 TACE治疗中晚期原发性肝癌疗效确切,能够显著延长患者的生存期,提高其生存质量。
Objective To evaluate the therapeutic effect and toxicities of transcatheter arterial chemoembolization （TACE） in the treatment of middle and advanced hepatic carcinoma. Methods The 120 patients with middle and advanced hepatic carcinoma were undergone selective hepatic artery catheter purfusion chemotherapy combined with iodizedoil embolism or gelfoam through femoral artery using Seldinger technique totally. All the patients received the 280 times of TACE. Results Of the 120 patients,the CR rate was 60.0% （72/120） ,the PR rate was 31.7% （38/120） ,the NC rate was 8.3% （10/120）. The 12-month survival rate was 63.3% （76/120）. Conclusion For the patients with middle and advanced hepatic carcinoma,TACE is effective,it can prolong survival time and improve life of quality.
出处
《肿瘤基础与临床》
2012年第3期219-221,共3页
journal of basic and clinical oncology
关键词
原发性肝癌
介入放射学
肝动脉化疗栓塞术
hepatic carcinoma
interventional therapy
transcatheter arterial chemoembolization
